These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9797870)
1. MuLV-based vectors pseudotyped with truncated HIV glycoproteins mediate specific gene transfer in CD4+ peripheral blood lymphocytes. Lodge R; Subbramanian RA; Forget J; Lemay G; Cohen EA Gene Ther; 1998 May; 5(5):655-64. PubMed ID: 9797870 [TBL] [Abstract][Full Text] [Related]
2. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618 [TBL] [Abstract][Full Text] [Related]
3. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556 [TBL] [Abstract][Full Text] [Related]
4. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Indraccolo S; Minuzzo S; Feroli F; Mammano F; Calderazzo F; Chieco-Bianchi L; Amadori A Gene Ther; 1998 Feb; 5(2):209-17. PubMed ID: 9578840 [TBL] [Abstract][Full Text] [Related]
5. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes. Thaler S; Schnierle BS Mol Ther; 2001 Sep; 4(3):273-9. PubMed ID: 11545619 [TBL] [Abstract][Full Text] [Related]
6. Gene transfer in human skin with different pseudotyped HIV-based vectors. Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532 [TBL] [Abstract][Full Text] [Related]
7. Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection. Hagani AB; Rivière I; Tan C; Krause A; Sadelain M J Gene Med; 1999; 1(5):341-51. PubMed ID: 10738551 [TBL] [Abstract][Full Text] [Related]
8. MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes. Gladow M; Becker C; Blankenstein T; Uckert W J Gene Med; 2000; 2(6):409-15. PubMed ID: 11199261 [TBL] [Abstract][Full Text] [Related]
9. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Schnierle BS; Stitz J; Bosch V; Nocken F; Merget-Millitzer H; Engelstädter M; Kurth R; Groner B; Cichutek K Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8640-5. PubMed ID: 9238030 [TBL] [Abstract][Full Text] [Related]
10. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model. Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881 [TBL] [Abstract][Full Text] [Related]
11. High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction. Yu H; Eton D; Wang Y; Kumar SR; Tang L; Terramani TT; Benedict C; Hung G; Anderson WF Gene Ther; 1999 Nov; 6(11):1876-83. PubMed ID: 10602383 [TBL] [Abstract][Full Text] [Related]
12. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems. Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669 [TBL] [Abstract][Full Text] [Related]
13. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262 [TBL] [Abstract][Full Text] [Related]
14. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems. Luo T; Douglas JL; Livingston RL; Garcia JV Virology; 1998 Feb; 241(2):224-33. PubMed ID: 9499797 [TBL] [Abstract][Full Text] [Related]
15. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838 [TBL] [Abstract][Full Text] [Related]
16. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein. Suzuki S; Shimada T Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520 [TBL] [Abstract][Full Text] [Related]
17. Kinetic analyses of stability of simple and complex retroviral vectors. Higashikawa F; Chang L Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826 [TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403 [TBL] [Abstract][Full Text] [Related]
19. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells. Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949 [TBL] [Abstract][Full Text] [Related]
20. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients. Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Fanning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray J; Gerlach W; Sun LQ; Penny R; Symonds GP; Carr A; Cooper DA J Gene Med; 2005 May; 7(5):552-64. PubMed ID: 15655805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]